Salinomycin can effectively kill ALDHhigh stem-like cells on gastric cancer

Biomedicine and Pharmacotherapy

Volumn 65, Issue 7, 2011, Pages 509-515

  Zhi, Qiao Ming ^a   Chen, Xue Hua ^a   Ji, Jun ^a   Zhang, Jia Nian ^a   Li, Jian Fang ^a   Cai, Qu ^a   Liu, Bing Ya ^a   Gu, Qin Long ^a   Zhu, Zheng Gang ^a   Yu, Ying Yan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Aldehyde dehydrogenase; Gastric cancer; Salinomycin

Indexed keywords

ALDEHYDE DEHYDROGENASE; CISPLATIN; FLUOROURACIL; MESSENGER RNA; SALINOMYCIN;

ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER STEM CELL; CHEMOSENSITIVITY; CONTROLLED STUDY; CULTURE MEDIUM; DOSE RESPONSE; DRUG SELECTIVITY; DRUG TARGETING; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR SPHEROID;

ALDEHYDE DEHYDROGENASE; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, ALKYLATING; CISPLATIN; ENZYME INDUCTION; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; INTERMEDIATE FILAMENT PROTEINS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PYRANS; RNA, MESSENGER; RNA, NEOPLASM; SOXB1 TRANSCRIPTION FACTORS; SPHEROIDS, CELLULAR; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 80555149348     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2011.06.006     Document Type: Article

References (34)

1. Kim C.F., Dirks P.B. Cancer and stem cell biology: how tightly intertwined?. Cell Stem Cell 2008, 3:147-150.
2. Tan B.T., Park C.Y., Ailles L.E., Weissman I.L. The cancer stem cell hypothesis: a work in progress. Lab Invest 2006, 86:1203-1207.
3. Prince M.E., Sivanandan R., Kaczorowski A., Wolf G.T., Kaplan M.J., Dalerba P., et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 2007, 104:973-978.
4. Gilbert C.A., Ross A.H. Cancer stem cells: cell culture, markers, and targets for new therapies. J Cell Biochem 2009, 108:1031-1038.
5. Kusumbe A.P., Bapat S.A. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res 2009, 69:9245-9253.
6. Dean M., transporters A.B.C. drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia 2009, 14:3-9.
7. Liscovitch M., Lavie Y. Cancer multidrug resistance: a review of recent drug discovery research. IDrugs 2002, 5:349-355.
8. Gupta P.B., Onder T.T., Jiang G., Tao K., Kuperwasser C., Weinberg R.A., et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138:645-659.
9. Fuchs D, Daniel V, Sadeghi M, Opelz G, Naujokat C. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun 394:1098-104.
10. Fuchs D., Heinold A., Opelz G., Daniel V., Naujokat C. Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells. Biochem Biophys Res Commun 2009, 390:743-749.
11. Riccioni R., Dupuis M.L., Bernabei M., Petrucci E., Pasquini L., Mariani G., et al. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. Blood Cells Mol Dis 2010, 45:86-92.
12. Croker A.K., Goodale D., Chu J., Postenka C., Hedley B.D., Hess D.A., et al. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med 2009, 13:2236-2252.
13. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567.
14. Ma S., Chan K.W., Lee T.K., Tang K.H., Wo J.Y., Zheng B.J., et al. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 2008, 6:1146-1153.
15. Ucar D., Cogle C.R., Zucali J.R., Ostmark B., Scott E.W., Zori R., et al. Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem Biol Interact 2009, 178:48-55.
16. Basak S.K., Veena M.S., Oh S., Huang G., Srivatsan E., Huang M., et al. The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer. PLoS One 2009, 4:e5884.
17. Jimeno A., Feldmann G., Suarez-Gauthier A., Rasheed Z., Solomon A., Zou G.M., et al. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol Cancer Ther 2009, 8:310-314.
18. Burger P.E., Gupta R., Xiong X., Ontiveros C.S., Salm S.N., Moscatelli D., et al. High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells 2009, 27:2220-2228.
19. Wang L., Park P., Zhang H., La Marca F., Lin C.Y. Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity. Int J Cancer 2010, 128:294-303.
20. Deng S., Yang X., Lassus H., Liang S., Kaur S., Ye Q., et al. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One 2010, 5:e10277.
21. Ignatova T.N., Kukekov V.G., Laywell E.D., Suslov O.N., Vrionis F.D., Steindler D.A. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002, 39:193-206.
22. Purohit G.N., Brady M.S., Sharma S.S. Influence of epidermal growth factor and insulin-like growth factor 1 on nuclear maturation and fertilization of buffalo cumulus oocyte complexes in serum free media and their subsequent development in vitro. Anim Reprod Sci 2005, 87:229-239.
23. Dalerba P., Cho R.W., Clarke M.F. Cancer stem cells: models and concepts. Annu Rev Med 2007, 58:267-284.
24. Sun S., Wang Z. ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis. Biochem Biophys Res Commun 2010, 396:843-848.
25. Chen Y.C., Chen Y.W., Hsu H.S., Tseng L.M., Huang P.I., Lu K.H., et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 2009, 385:307-313.
26. Douville J., Beaulieu R., Balicki D. ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev 2009, 18:17-25.
27. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
28. Rich J.N., Bao S. Chemotherapy and cancer stem cells. Cell Stem Cell 2007, 1:353-355.
29. Ning Z.F., Huang Y.J., Lin T.X., Zhou Y.X., Jiang C., Xu K.W., et al. Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24. J Int Med Res 2009, 37:621-630.
30. Dou J., Pan M., Wen P., Li Y., Tang Q., Chu L., et al. Isolation and identification of cancer stem-like cells from murine melanoma cell lines. Cell Mol Immunol 2007, 4:467-472.
31. Fuchs D., Daniel V., Sadeghi M., Opelz G., Naujokat C. Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem Biophys Res Commun 2010, 394:1098-1104.
32. Arkenau H.T. Gastric cancer in the era of molecularly targeted agents: current drug development strategies. J Cancer Res Clin Oncol 2009, 135:855-866.
33. Hashimoto I., Koizumi K., Tatematsu M., Minami T., Cho S., Takeno N., et al. Blocking on the CXCR4/mTOR signalling pathway induces the anti-metastatic properties and autophagic cell death in peritoneal disseminated gastric cancer cells. Eur J Cancer 2008, 44:1022-1029.
34. Wu K., Nie Y., Guo C., Chen Y., Ding J., Fan D. Molecular basis of therapeutic approaches to gastric cancer. J Gastroenterol Hepatol 2009, 24:37-41.